Intraocular lens developer LensGen announced today that it received FDA investigational device exemption (IDE) for its Juvene lens. Irvine, California-based LensGen designed the Juvene intraocular lens (IOL) for patients with cataracts, with the IDE set to initiate a pivotal study for the device. The company developed Juvene IOL t0 permanently restore clear and continuous vision at […]
lensgen
LensGen closes $10 million in bridge financing
Intraocular lens developer LensGen announced today that it closed the addition of $10 million in a $20 million bridge financing. HOYA Group’s corporate investment arm led the financing, which is part of a larger Series B round planned for early 2021 that is earmarked for funding the company through the approval of a pivotal FDA study […]
New eye health companies gain funders’ focus
Startups pioneering less-invasive technologies to treat common eye diseases are changing the outlook for both patients and the industry. A new study by CB Insights revealed that investors have been pouring money into smaller companies in 2017 and 2018, with some FDA approvals to begin marketing their technologies and treatments. These firms are eyeing conditions […]
LensGen updates on Juvene IOL, adds $15m to Series A
Intraocular lens developer LensGen said today it hit clinical performance milestones that triggered the release of $11 million that was part of its Series A financing round, and added that lead investor Hoya opted to invest an additional $4.4 million. The Irvine, Calif.-based company also said it is expanding from its current office location into a 14,000 […]
LensGen raises $7.3m
Intraocular lens developer LensGen raised $7.3 million in a new round of equity funding, according to an SEC filing posted this week. The Irvine, Calif.-based company develops the Juvene accommodating intraocular lens. The Juvene lens is designed to potentially permanently restore clear and continuous vision at all distances for patients with cataracts and presbyopia, LensGen […]
LensGen raises $21m in Series A
Ophthalmic device developer LensGen said today it closed a $21 million Series A financing round to support its Juvene accommodating intraocular lens. The financing round was led by the corporate venture investment arm of Hoya Group and was joined by Relativity Healthcare Partners, the Irvine, Calif.-based company said. “As one of the leading global intraocular […]
